Equivalence of Glatiramer Acetate Generics With Branded Glatiramer Acetate in Efficacy and Cost for the Treatment of Multiple Sclerosis

被引：8
|
作者：
Bourdette, Dennis [1 ,2 ]
Hartung, Daniel [3 ]
机构：
[1] Oregon Hlth & Sci Univ, Dept Neurol, Portland, OR 97239 USA
[2] Vet Affairs Portland Hlth Care Syst, Multiple Sclerosis Ctr Excellence West, Portland, OR USA
[3] Oregon Hlth & Sci Univ, Oregon State Univ, Coll Pharm, Portland, OR 97201 USA
来源：
JAMA NEUROLOGY | 2015年 / 72卷 / 12期
关键词：
TRIAL; MULTICENTER; COPAXONE(R); COP-1; DRUGS;
D O I：
10.1001/jamaneurol.2015.2605
中图分类号：
R74 [神经病学与精神病学];
学科分类号：
摘要：
引用
收藏
页码：1411 / 1413
页数：4
相关论文
共 50 条
  • [31] Lipoatrophy associated with glatiramer acetate injections for the treatment of multiple sclerosis
    Hwang, L
    Orengo, I
    CUTIS, 2001, 68 (04): : 287 - 288
  • [32] Glatiramer acetate for treatment of relapsing-remitting multiple sclerosis
    Johnson, Kenneth P.
    EXPERT REVIEW OF NEUROTHERAPEUTICS, 2012, 12 (04) : 371 - 384
  • [33] Lymphadenopathy in patients with multiple sclerosis undergoing treatment with glatiramer acetate
    Windhagen, A
    Maniak, S
    Marckmann, S
    Wilkening, A
    Lindert, RB
    Heidenreich, F
    Blasczyk, R
    JOURNAL OF NEUROLOGY NEUROSURGERY AND PSYCHIATRY, 2001, 70 (03): : 415 - 416
  • [34] Neuroprotection and glatiramer acetate: The possible role in the treatment of Multiple Sclerosis
    Ziemssen, T
    FRONTIERS IN CLINICAL NEUROSCIENCE: NEURODEGENERATION AND NEUROPROTECTION: A SYMPOSIUM IN ABEL LAJTHA'S HONOUR, 2004, 541 : 111 - 134
  • [35] The effect of glatiramer acetate treatment on axonal integrity in multiple sclerosis
    Narayanan, S
    Caramanos, Z
    Arnold, D
    MULTIPLE SCLEROSIS, 2004, 10 (7032): : S256 - S256
  • [36] Mechanisms of action of glatiramer acetate in multiple sclerosis
    Neuhaus, O
    Farina, C
    Wekerle, H
    Hohlfeld, R
    NEUROLOGY, 2001, 56 (06) : 702 - 708
  • [37] Long-term treatment of multiple sclerosis with glatiramer acetate: Natural history of the subtypes of anti-glatiramer acetate antibodies and their correlation with clinical efficacy
    Karussis, Dimitros
    Teitelbaum, Dvora
    Sicsic, Camille
    Brenner, Talma
    JOURNAL OF NEUROIMMUNOLOGY, 2010, 220 (1-2) : 125 - 130
  • [38] Spasticity in multiple sclerosis: a pilot study to evaluate the efficacy of glatiramer acetate
    Meca-Lallana, Jose
    MULTIPLE SCLEROSIS, 2008, 14 : S165 - S165
  • [39] Treatment with glatiramer acetate (Copaxone®) prevents neurodegeneration in patients with multiple sclerosis
    Jaworski, J.
    Leinhard, O. Dahlqvist
    Tisell, A.
    Lundberg, P.
    Landtblom, A. M.
    MULTIPLE SCLEROSIS, 2009, 15 (09): : S140 - S141
  • [40] Molecular profiling of glatiramer acetate early treatment effects in multiple sclerosis
    Anat, Achiron
    Anna, Feldman
    Michael, Gurevich
    DISEASE MARKERS, 2009, 27 (02) : 63 - 73
12345